MANNKIND CORP Deferred Tax Liabilities, Prepaid Expenses
MANNKIND CORP (MNKD) had Deferred Tax Liabilities, Prepaid Expenses of $262.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPrepaidExpenses · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Prepaid Expenses $262.00K.
- 2024-12-31: Deferred Tax Liabilities, Prepaid Expenses $204.00K.
- 2023-12-31: Deferred Tax Liabilities, Prepaid Expenses $176.00K.
- 2022-12-31: Deferred Tax Liabilities, Prepaid Expenses $249.00K.
| Period end | Deferred Tax Liabilities, Prepaid Expenses |
|---|---|
| 2025-12-31 | $262.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $204.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $176.00K 10-K · filed 2025-02-26 |
| 2022-12-31 | $249.00K 10-K · filed 2024-02-27 |
| 2021-12-31 | $272.00K 10-K · filed 2023-02-23 |
| 2020-12-31 | $232.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $207.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |